USFDA Approves Johnson and Johnson’s Blood Cancer Drug Tecvayli-Darzalex Combo via Fast-Track Voucher Program
Bengaluru: The U.S. Food and Drug Administration on Thursday approved Johnson & Johnson's treatment for a type of blood cancer, making it the third drug cleared under the agency's new…